https://www.selleckchem.com/pr....oducts/3-methyladeni
39, 95% CI, 0.59-3.29, p=0.09) and warfarin. The combined results of major bleeding in the apixaban group were not affected by the sensitivity analysis. Apixaban may have a lower risk of major bleeding and comparable risk of stroke when compared with warfarin in AF patients with ESRD. Apixaban may have a lower risk of major bleeding and comparable risk of stroke when compared with warfarin in AF patients with ESRD.The anti-inflammatory action of adrenal-derived glucocorticoids has been recognized since several decades. This know
Like
Comment
Share
